Skip to main content
. 2009 Jan 10;27(2):193–198. doi: 10.1200/JCO.2008.18.9514

Table 3.

Tumor Response Among Patients Receiving RAD001

Disease Response No. %
Complete or partial response 0 0
Stable disease, months 7 21
    > 2 6 18
    > 4 1 3
Progressive disease 22 67
Not assessable* 4 12
*

Three patients were removed from study because of withdrawal of consent without documented progressive disease by Response Evaluation Criteria in Solid Tumors guidelines. One patient was removed from study after 8 days of treatment because of worsening of a preexisting perirectal fistula, requiring surgical intervention.